Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Tom, Caroline
NCT05230537: A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration	Recruiting	2	146	Europe, US, RoW	Iptacopan (LNP023), Placebo	Novartis Pharmaceuticals	Age-Related Macular Degeneration	10/26	10/26
Haug, Sara
NCT05230537: A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration	Recruiting	2	146	Europe, US, RoW	Iptacopan (LNP023), Placebo	Novartis Pharmaceuticals	Age-Related Macular Degeneration	10/26	10/26
Bawcombe, w Philip
NCT05230537: A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration	Recruiting	2	146	Europe, US, RoW	Iptacopan (LNP023), Placebo	Novartis Pharmaceuticals	Age-Related Macular Degeneration	10/26	10/26